Symbols

BPTS(Delisted)

Biophytis·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About BPTS

Biophytis S.A.

A clinical-stage biotech company focused on developing innovative treatments for age-related diseases

Industry

Established Date

09/27/2006

Listing Date

02/10/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.biophytis.com

Security Type

Depository Receipts (Ordinary Shares)

Office address

14 Avenue de l'Opera, FR-75001 Paris, France

Business

Introduction

Biophytis S.A. is a clinical-stage biotechnology company specializing in the development of drug candidates to slow the aging process and improve the functioning of patients with age-related diseases, including respiratory failure in patients with COVID 19. The company is located in Paris, France and Cambridge, Massachusetts.

Company Financials

EPS

BPTS has released its 2022 Q1 earnings. EPS was reported at -0.31, versus the expected 0, missing expectations. The chart below visualizes how BPTS has performed over recent quarters, highlighting trends in earnings surprises.